医学
血管瘤
脾脏
放射科
腺癌
病变
活检
鉴别诊断
核医学
病理
癌症
内科学
作者
Jia Ge,Aisheng Dong,Chao Cheng,Chuantao Zuo
出处
期刊:Clinical Nuclear Medicine
[Ovid Technologies (Wolters Kluwer)]
日期:2023-11-30
卷期号:49 (2): e90-e92
被引量:1
标识
DOI:10.1097/rlu.0000000000004995
摘要
Abstract A 77-year-old man was referred for 18 F-PSMA-1007 PET/CT scan for initial staging of biopsy-proved prostate adenocarcinoma. 18 F-PSMA-1007 PET/CT showed focal intense 18 F-PSMA-1007 of the prostate adenocarcinoma and a focal intense activity (SUV max , 27) in the spleen. The 18 F-PSMA-1007–avid splenic lesion corresponded to a splenic hemangioma, which was initially detected on contrast-enhanced CT 7 months ago and unchanged in size and enhancement pattern on follow-up contrast-enhanced CT. This case indicates that splenic hemangioma should be included in the differential diagnosis of PSMA-avid splenic lesions.
科研通智能强力驱动
Strongly Powered by AbleSci AI